Notre Dame Patient Advocacy Initiative receives support from Dyne Therapeutics
Dyne Therapeutics, a leading muscle disease company focused on advancing innovative, life-transforming therapeutics for people living with genetically driven diseases, has made a commitment of $500,000 over five years in support of the University of Notre Dame’s Patient Advocacy Initiative. In addition, Dyne has pledged a similar amount of in-kind support for the program.
The Notre Dame Patient Advocacy Initiative is centered on the interdisciplinary minor in science and patient advocacy and draws on the University’s research strength in rare and neglected diseases. It is estimated that 30 million people in the United States, or 1 in 10, are living with a rare medical condition. Although understanding the experience of a person with a rare disease can enable improved health, faster and more accurate diagnosis, and better care for individuals and families living with rare diseases, medical professionals often do not receive training to recognize a patient with one of the nearly 8,000 identified rare diseases.
“We are thankful for the leadership of Dyne Therapeutics to partner with us in this endeavor,” Santiago Schnell, the William K. Warren Foundation Dean of the College of Science, said. “Their support acknowledges Notre Dame’s expertise in rare disease research and demonstrates faith in our ability to educate future patient advocates. This gift will train our future physicians, researchers and industry professionals to be forces for good for patients with rare diseases.”
Beyond the generous financial support provided, the partnership will leverage the talent, expertise and reach of Dyne Therapeutics to promote patient-informed rare disease training, advocacy and research.
“We are excited to partner with Dyne to build connections between rare disease stakeholders and to train the next generation of health care providers and industry professionals, with the ultimate goal of elevating the voice of the patient community to build awareness of rare diseases,” Barbara Calhoun, director of patient advocacy education and outreach at Notre Dame, said.
Dyne Therapeutics joined forces with Notre Dame to sponsor an inaugural Patient Advocacy Summit in the fall of 2021. Its financial and in-kind support will enable the University to expand this and other education and outreach programs to better serve the rare disease community.
“We’re proud to partner with Notre Dame to advance our shared commitment to patient advocacy,” Joshua Brumm, president and chief executive officer of Dyne, said. “The University’s minor program is a unique initiative that will help students understand the power of engaging the rare disease patient community in advancing drug development and improving clinical care. A medical degree isn’t the only way for students to make a difference in a patient’s life. We were pleased to be a part of the initiative’s first summit and host student interns this summer, and we look forward to continuing to support this effort to prepare today’s students to be tomorrow’s leaders in careers focused on advancing patient care.”
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen with other approaches. Dyne has a broad portfolio of programs for serious muscle diseases, including candidates for myotonic dystrophy type 1, Duchenne muscular dystrophy and facioscapulohumeral muscular dystrophy.
Latest Colleges & Schools
- Essays on democracy draw attention to critical threats, explore safeguards ahead of Jan. 6Shortly after Jan. 6, 2021, when a mob stormed the U.S. Capitol building, Notre Dame’s Rooney Center for the Study of American Democracy established the January 6th, 2025, Project, which includes 10 Notre Dame faculty who are preeminent scholars of democracy. In an effort to understand the social, political, psychological and demographic factors that led to that troublesome day, the group created a collection of 14 essays aimed at drawing attention to the vulnerabilities in our democratic system and the threats building against it, hoping to create consensus on ways to remedy both problems.
- Graduate students to present research, compete for prize money in annual Three Minute Thesis competitionNine University of Notre Dame graduate students will compete for $4,500 in prize money during the annual Shaheen Three Minute Thesis (3MT) competition. The competition will take place from 5 to 7 p.m. Wednesday (Feb. 28) inside Jordan Auditorium at the Mendoza College of Business on campus. It is open to the public.
- Does Russia stand to benefit from climate change?There exists a narrative about climate change that says there are winners and losers — with Russia being one of the countries that stand to benefit from its effects. In a new study, researchers at the University of Notre Dame found that Russia is suffering from a variety of climate change impacts and is ill-prepared to mitigate or adapt to those climate impacts. And, as the rest of the world transitions to renewable energy sources, Russia’s fossil-fuel-dependent government is not willing or ready to make alternative plans for the country, changes that could potentially benefit the whole of their society.
- ‘I’m watching you’ behavior produces racial disparities in school disciplineResearch from Calvin Zimmermann, the O’Shaughnessy Assistant Professor of Education in Notre Dame's Department of Sociology, indicates that early childhood teachers often apply discipline disproportionately in their classrooms based on a student’s race.
- Solar eclipse-focused events lead up to watch party on April 8The College of Science at Notre Dame has public lectures and eclipse-themed planetarium shows planned both on and off campus in the weeks and days leading up to the near-total solar eclipse on April 8, when an eclipse watch party is planned. Each event is free and open to the public.
- Notre Dame Ethics Week explores artificial intelligenceThe 2024 series features Mendoza faculty members renowned for their research and expertise in the use and development of AI.